New treatment modalities in the early stage and locally advanced non-small cell lung cancer


Klin Onkol 2021; 34(Suppl 1): 43-47. DOI: 10.48095/ccko202143.

The lung cancer dia­gnosis is still connected with high mortality. Even the new anticancer drugs are not able to preserve long survival in the advanced lung cancer patients. Only a minority of patients is diagnosed with early or locally advanced stages. In the following review, we present interesting data regarding the treatment updates in these potentially curable patients.

Full text in PDF